Related Experiment Video
Updated: Apr 18, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Personalization algorithms applied to cardiovascular disease risk assessment
Insights
Personalizing cardiovascular disease (CVD) risk assessment improves patient stratification. A similarity measures approach enhanced accuracy in identifying CVD risk, outperforming current tools for Acute Coronary Syndrome patients.
Area of Science:
- Cardiology
- Medical Informatics
- Health Services Research
Background:
- Cardiovascular disease (CVD) is a leading global cause of mortality.
- Current clinical guidelines utilize risk assessment tools for patient CVD risk stratification.
- Existing tools may exhibit variable performance across different patient populations.
Purpose of the Study:
- To explore personalized CVD risk assessment strategies.
- To develop and validate patient grouping methodologies for enhanced risk prediction.
- To compare the performance of novel personalization methods against existing CVD risk assessment tools.
Main Methods:
- Developed two patient personalization methods: a clustering approach and a similarity measures approach.
- Validated these methodologies using data from 460 Portuguese Acute Coronary Syndrome with non-ST segment elevation (ACS-NSTEMI) patients.
- Evaluated the sensitivity, specificity, and geometric mean of the proposed methods.
Main Results:
- The similarity measures approach demonstrated superior performance compared to the clustering method.
- The similarity measures approach achieved a sensitivity of 77.7%, specificity of 63.2%, and geometric mean of 69.7%.
- These results represent an improvement over the performance of current CVD risk assessment tools (78.5%, 53.2%, 64.4% respectively).
Conclusions:
- Personalized CVD risk assessment, particularly using similarity measures, can optimize patient stratification.
- The similarity measures approach offers enhanced accuracy for CVD risk prediction in ACS-NSTEMI patients.
- This study highlights the potential of tailored risk assessment to improve healthcare strategies for cardiovascular events.
Abstract:
Cardiovascular disease (CVD) is the major cause of death in the world. Clinical guidelines recommend the use of risk assessment tools (scores) to identify the CVD risk of each patient as the correct stratification of patients may significantly contribute to the optimization of the health care strategies. This work further explores the personalization of CVD risk assessment, supported on the evidence that a specific CVD risk assessment tool may have good performance within a given group of patients and might perform poorly within other groups. Two main personalization methods based on the proper creation of groups of patients are presented: i) clustering patients approach; ii) similarity measures approach. These two methodologies were validated in a Portuguese population (460 Acute Coronary Syndrome with non-ST segment elevation (ACS-NSTEMI) patients). The similarity measures approach had the best performance, achieving maximum values of sensitivity, specificity and geometric mean of, respectively, 77.7%, 63.2%, 69.7%. These values represent an enhancement in relation to the best performance obtained with current CVD risk assessment tools applied in clinical practice (78.5%, 53.2%, 64.4%).
More Related Videos
08:21Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Coronary Artery Disease I: Introduction
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Pre-Procedural Guidelines for Assessing Blood Pressure